Laura M. Shelton
Laura M. Shelton
Human Metabolome Technologies
Verified email at humanmetabolome.com
Title
Cited by
Cited by
Year
Cancer as a metabolic disease
TN Seyfried, LM Shelton
Nutrition & metabolism 7 (1), 7, 2010
6142010
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
D Kim, BP Fiske, K Birsoy, E Freinkman, K Kami, RL Possemato, ...
Nature 520 (7547), 363-367, 2015
2172015
Metabolic management of brain cancer
TN Seyfried, MA Kiebish, J Marsh, LM Shelton, LC Huysentruyt, ...
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1807 (6), 577-594, 2011
1402011
Differential glutamate metabolism in proliferating and quiescent mammary epithelial cells
JL Coloff, JP Murphy, CR Braun, IS Harris, LM Shelton, K Kami, SP Gygi, ...
Cell metabolism 23 (5), 867-880, 2016
1382016
PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis
D Samanta, Y Park, SA Andrabi, LM Shelton, DM Gilkes, GL Semenza
Cancer research 76 (15), 4430-4442, 2016
1082016
Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model
LC Huysentruyt, P Mukherjee, D Banerjee, LM Shelton, TN Seyfried
International journal of cancer 123 (1), 73-84, 2008
822008
Glutamine targeting inhibits systemic metastasis in the VM‐M3 murine tumor model
LM Shelton, LC Huysentruyt, TN Seyfried
International journal of cancer 127 (10), 2478-2485, 2010
802010
Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?
TN Seyfried, J Marsh, LM Shelton, LC Huysentruyt, P Mukherjee
Epilepsy research 100 (3), 310-326, 2012
752012
Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse
LM Shelton, LC Huysentruyt, P Mukherjee, TN Seyfried
ASN neuro 2 (3), AN20100002, 2010
682010
Arginine deprivation inhibits the Warburg effect and upregulates glutamine anaplerosis and serine biosynthesis in ASS1-deficient cancers
JC Kremer, BC Prudner, SES Lange, GR Bean, MB Schultze, ...
Cell reports 18 (4), 991-1004, 2017
582017
Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a
P Mukherjee, AC Faber, LM Shelton, RC Baek, TC Chiles, TN Seyfried
Journal of lipid research 49 (5), 929-938, 2008
502008
Does the existing standard of care increase glioblastoma energy metabolism?
TN Seyfried, LM Shelton, P Mukherjee
The lancet oncology 11 (9), 811-813, 2010
492010
A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion
LM Shelton, P Mukherjee, LC Huysentruyt, I Urits, JA Rosenberg, ...
Journal of neuro-oncology 99 (2), 165-176, 2010
472010
MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naive state
BJ Smagghe, AK Stewart, MG Carter, LM Shelton, KJ Bernier, EJ Hartman, ...
PLoS One 8 (3), e58601, 2013
312013
Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer
LC Huysentruyt, LM Shelton, TN Seyfried
International journal of cancer 126 (1), 65-72, 2010
292010
Provocative question: should ketogenic metabolic therapy become the standard of care for glioblastoma?
TN Seyfried, L Shelton, G Arismendi-Morillo, M Kalamian, A Elsakka, ...
Neurochemical research 44 (10), 2392-2404, 2019
202019
Ganglioside GM3 suppresses the pro-angiogenic effects of vascular endothelial growth factor and ganglioside GD1A
P Mukherjee, AC Faber, LM Shelton, RC Baek, TC Chiles, TN Seyfried
J Lipid Res 49 (5), 929-938, 2008
202008
Quantification of folate metabolism using transient metabolic flux analysis
PM Tedeschi, N Johnson-Farley, H Lin, LM Shelton, T Ooga, G Mackay, ...
Cancer & metabolism 3 (1), 1-14, 2015
152015
Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells
RE Flores, AK Brown, L Taus, J Khoury, F Glover, K Kami, ...
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1859 (9), 975-983, 2018
102018
Krebs cycle substrate-level phosphorylation drives metastatic cancer cells
LM Shelton, CL Strelko, MF Roberts, TN Seyfried
Cancer Research 70 (8 Supplement), 53-53, 2010
72010
The system can't perform the operation now. Try again later.
Articles 1–20